| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net gain before income taxes | NaN | 17,770,959 | -2,644,625 | -3,209,094 |
| Gain on disposal of nti (note 4) | NaN | 767,258.5* | 0 | -1,534,517 |
| Loss on discontinued operations of nti (note 4) | NaN | -2,201,847* | 0 | -541,247 |
| Provision (benefit) for income taxes | NaN | 14,326,355.5 | 0 | 0 |
| Gain on changes in fair value | NaN | 3,662,517* | NaN | NaN |
| Total revenue | 2,015,225 | 1,583,317 | 1,757,094 | 1,863,654 |
| Gain from debt extinguishment | NaN | 216,798.5* | -876,165 | -692,270 |
| Research and development expenses | NaN | NaN | 0 | 0 |
| Gain on lease termination | NaN | NaN | 0 | 0 |
| Impairment loss | NaN | NaN | 0 | 1,397,353 |
| (gain) loss on disposal of fixed assets | NaN | NaN | 0 | 0 |
| Cost of services | 1,282,247 | -14,221,256* | 1,127,749 | 1,093,603 |
| Cost of goods sold | 5,152 | 7,642.75* | NaN | NaN |
| Selling, general and administrative expenses | 2,176,099 | 815,540 | 2,128,088 | 2,193,049 |
| Impairment of intangible assets | NaN | 349,338.25* | NaN | NaN |
| Depreciation and amortization | 142,698 | 136,424 | 136,741 | 169,737 |
| Total operating expenses | 3,606,196 | -12,912,311 | 3,392,578 | 4,853,742 |
| Gain on settlement (note 17) | NaN | NaN | 0 | 714,500 |
| Gain from operations | -1,590,971 | 14,495,628 | -1,635,484 | -2,990,088 |
| Gain from equity method investment | 22,168 | 23,282 | 12,827 | -19,911 |
| Loss on changes in fair value on warrant liability | 3,790,225 | 235,965.5* | NaN | NaN |
| Gain on settlement of liability (note 18) | NaN | 232,375* | NaN | NaN |
| Interest expense | 180,323 | 623,676 | 145,803 | 221,325 |
| Total other income (expense) | -3,948,380 | 3,275,331 | -1,009,141 | -219,006 |
| Net gain from continuing operations | -5,539,351 | 3,444,603.5* | -2,644,625 | -3,209,094 |
| Net gain | -5,539,351 | 2,010,015 | -2,644,625 | -5,284,858 |
| Preferred stock dividends and deemed dividends | NaN | 1,807,170 | NaN | NaN |
| Net loss attributable to common shareholders | NaN | 202,845 | NaN | NaN |
| Basic EPS | -3.38 | 1.732 | -0.77 | -13.3 |
| Diluted EPS | -3.38 | 1.732 | -0.77 | -13.3 |
| Basic Average Shares | 1,637,859 | 117,083* | 3,447,622 | 397,440 |
| Diluted Average Shares | 1,637,859 | 117,083* | 3,447,622 | 397,440 |
INVO Fertility, Inc. (IVF)
INVO Fertility, Inc. (IVF)